Cardlytics, Inc. CDLX

About Cardlytics, Inc. (CDLX): stock profile, AI score and financials

Cardlytics, Inc. (CDLX) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores CDLX at 19.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,763 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (3.1) and balance sheet strength (6.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 13.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Cardlytics, Inc. reports quarterly revenue of $36.9M, net income of $-14.9M, an operating margin of -14.8%. Top institutional holders of CDLX by reported 13-F value include PenderFund Capital Management Ltd., 683 Capital Management, CAPSTONE INVESTMENT ADVISORS, based on the most recent SEC filings. CDLX trades on the Nasdaq exchange and files with the SEC under CIK 1666071. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CDLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cardlytics, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1666071 →